FindTrial
Sign In

Feasibility study for gene methylation and chemosensitivity of cervical cancer

Feasibility study for gene methylation and chemosensitivity of cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018801
Enrollment
Unknown
Registered
2018-10-10
Start date
2018-10-10
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Case series:Nil

Sponsors

Hu'nan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Cervical cancer patients from Hunan Cancer Hospital, Shandong Cancer Hospital, and Hubei Cancer Hospital from 2018 to 2021

Exclusion criteria

Exclusion criteria: No Exclusion criteria

Design outcomes

Primary

MeasureTime frame
Gene methylation;Gene methylation;Gene methylation;Gene methylation;—

Countries

China

Contacts

Public ContactWang Jing

Hu'nan Cancer Hospital

wangjing0081@hnszlyy.com+86 13875902083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026